Mach et al., 2008 - Google Patents
Reducing microbial contamination risk in biotherapeutic manufacturingMach et al., 2008
View PDF- Document ID
- 5757580606928079588
- Author
- Mach C
- Riedman D
- Publication year
- Publication venue
- BioProcess International
External Links
Snippet
The risk of contamination (especially microbiological) is always an area for special attention in biopharmaceutical processes. No matter the process stage, whether upstream of a bioreactor or in the final filling of a sterile product, effective contamination control continues …
- 238000011109 contamination 0 title abstract description 13
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW308644B (en) | ||
EP1135459A1 (en) | Method for culturing microorganisms in prefilled flexible containers | |
Allison et al. | Current status and future trends for disposable technology in the biopharmaceutical industry | |
Sigward et al. | Aseptic simulation test challenged with microorganisms for validation of pharmacy operators | |
Sandle et al. | Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals | |
Mach et al. | Reducing microbial contamination risk in biotherapeutic manufacturing | |
EP2840379B1 (en) | An automated test method for testing risk and integrity of pharmaceutical filtration membranes | |
US20190359930A1 (en) | Method for sampling fluid streams for monitoring contaminants in a continuous flow | |
Watson et al. | Scalable isolation and purification of extracellular vesicles from Escherichia coli and other bacteria | |
GERMS Group | False‐positive alarms for bacterial screening of platelet concentrates with BacT/ALERT new‐generation plastic bottles: a multicenter pilot study | |
Galliher | Single use technology and equipment | |
Plavsic | An integrated approach to ensure the viral safety of biotherapeutics | |
EP3141594A2 (en) | Method for sampling fluid streams for monitoring contaminants in a continuous flow | |
Hampson | Closed processing for cell therapies: engineering risk reduction and patient safety during manufacturing | |
Roesti | Microbiological examination of non‐sterile final dosage forms and raw material including acceptance criteria and testing frequency | |
Jornitz et al. | Single-use Equipment–The | |
Pendlebury | Cell & Gene Therapies: A Guide To Single-Use Connections-10 Transferable Lessons From The Bioprocessing Industry | |
Ebinuma et al. | Sterilization in pharmaceutical biotechnology | |
Amipara | Manufacturing of dry powder injection of cefoperazone+ sulbactam 1.5 gm IP | |
Ebinuma et al. | 8 Sterilization in Pharmaceutical Biotechnology | |
Pendlebury | CELL & GENE THERAPIES: A GUIDE TO SINGLE-USE CONNECTIONS | |
GRUENER | Guide to Irradiation and Sterilization Validation of Single-Use Bioprocess Systems | |
Cooper et al. | Bacterial endotoxin test and sterility test for radiopharmaceuticals | |
Wassard et al. | Rapid Implementation of a Smallpox Vaccine Facility | |
Weissfeld et al. | Microbial monitoring in the pharmacy |